H-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-OH manufacturers
|
| H-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-OH Basic information |
Product Name: | H-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-OH | Synonyms: | AQDFVQWLMNT;H-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-OH;GLUCAGON (19-29), BOVINE, HUMAN, PORCINE;GLUCAGON (19-29), HUMAN;GLUCAGON (19-29) (HUMAN, BOVINE, PORCINE);ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR;glucagon(19-29;PHE-VAL-GLN-TRP-LEU-MET-ASN-THR: FVQWLMNT | CAS: | 64790-15-4 | MF: | C61H89N15O18S | MW: | 1352.51 | EINECS: | | Product Categories: | Peptide;Obesity | Mol File: | 64790-15-4.mol | ![H-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-OH Structure](CAS/GIF/64790-15-4.gif) |
| H-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-OH Chemical Properties |
Boiling point | 1828.5±65.0 °C(Predicted) | density | 1.339±0.06 g/cm3(Predicted) | storage temp. | -15°C | solubility | insoluble in EtOH; insoluble in H2O; ≥135.2 mg/mL in DMSO | pka | 3.19±0.10(Predicted) | form | Powder | color | White to off-white |
| H-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-OH Usage And Synthesis |
Uses | This fragment inhibits calcium activated ATPase activity |
| H-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-OH Preparation Products And Raw materials |
|